CGAS and neoplasm: While defects in MMR reduced in vivo tumor growth in comparison to wild-type tumor cells, concomitant deletion of tumor cGAS, STING, or IFNAR1 rescued these growth defects, indicating a key role of cGAS/STING-type I IFN axis in immune surveillance (97).